Skip to main content

Merck

HEADLINE_ROUNDUP

Joseph Prezioso/AFP via Getty Images

Headline Roundup

Personalized mRNA Vaccine Reduces Risk of Melanoma Recurrence in Clinical Trials

mRNA Cancer Vaccine Succeeds in Late-Stage Trial, Companies Say

The Epoch Times

AllSides Media Bias Rating: Lean Right
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial

CNN Digital

AllSides Media Bias Rating: Lean Left
Moderna vaccine cuts recurrence and spread of high-risk melanoma, raising new treatment hope

Reuters

AllSides Media Bias Rating: Center
HEADLINE_ROUNDUP

Dreamstime

Headline Roundup

Paxlovid, Pfizer's COVID-19 Pill, May Mix Poorly With Other Common Medications

See how Newsmax (News), NBC News Digital, and The Hill cover this story.
HEADLINE_ROUNDUP

Merck/BBC News

Headline Roundup

UK Becomes First Country To Authorize Use Of Merck's COVID-19 Pill

See how BBC News, The Epoch Times, and The Washington Post cover this story.
More headline roundups

Balanced News about Merck on AllSides

News from the Left

News from the Center

News from the Right

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial

CNN Digital

AllSides Media Bias Rating: Lean Left
Moderna vaccine cuts recurrence and spread of high-risk melanoma, raising new treatment hope

Reuters

AllSides Media Bias Rating: Center
mRNA Cancer Vaccine Succeeds in Late-Stage Trial, Companies Say

The Epoch Times

AllSides Media Bias Rating: Lean Right
Experimental mRNA vaccines gain steam with promising cancer trial results

Semafor

AllSides Media Bias Rating: Lean Left
Red Cross Responds to Latest Tornadoes as Severe Weather Threat Continues

RedCross.org

Political News Media Bias Rating: Not Rated
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications

Newsmax (News)

AllSides Media Bias Rating: Right
Pfizer antiviral pills may be risky with other medications

NBC News Digital

AllSides Media Bias Rating: Lean Left
Merck sues government over drug price negotiation

Roll Call

AllSides Media Bias Rating: Center
UK Becomes First to Approve Antiviral Home Pill for COVID-19

The Epoch Times

AllSides Media Bias Rating: Lean Right
Britain authorizes Merck’s molnupiravir, the world’s first approval of oral covid-19 treatment pill

The Washington Post

AllSides Media Bias Rating: Lean Left
Pfizer antiviral pill could be risky with other widely used medications

The Hill

AllSides Media Bias Rating: Center
Merck asks FDA for emergency approval of its antiviral COVID-19 pill

New York Post (News)

AllSides Media Bias Rating: Right
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin

FactCheck.org

AllSides Media Bias Rating: Lean Left
8 lingering questions about the new Covid pills from Merck and Pfizer

STAT

AllSides Media Bias Rating: Center
Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA

Washington Times

AllSides Media Bias Rating: Lean Right
Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19

USA TODAY

AllSides Media Bias Rating: Lean Left
First pill to treat Covid gets approval in UK

BBC News

AllSides Media Bias Rating: Center
US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor

The Epoch Times

AllSides Media Bias Rating: Lean Right
Merck's promising experimental Covid-19 drug raises hopes for pill to fight virus

Politico

AllSides Media Bias Rating: Lean Left
What we know — and don’t know — about Merck’s new Covid-19 pill

STAT

AllSides Media Bias Rating: Center
Merck says experimental pill cuts worst effects of COVID-19

Associated Press

AllSides Media Bias Rating: Lean Left

Balanced News about Merck from Across the Web Powered by Google. Enhanced by AllSides.

AllSides Balanced Search™ gives you recent news from outlets on all sides of the political spectrum so you can get the full picture.